Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE10A | Q9Y233 | 5/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | FLT3 | P36888 | 2/20 | 0.38 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.36 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | BMX | P51813 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24674395 | 0.99 | PDE10A (0.42) | PDE10AKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL24674389 | 0.99 | PDE10A (0.42) | PDE10AKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL24674452 | 0.94 | KDM4E (0.38) | PDE10AKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL24674420 | 0.94 | PDE10A (0.38) | PDE10AKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL24674445 | 0.94 | PDE10A (0.38) | PDE10AKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL24674434 | 0.93 | PDE10A (0.39) | PDE10AKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL24674238 | 0.93 | PDE10A (0.39) | PDE10AKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL24674111 | 0.93 | PDE10A (0.39) | PDE10AKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL26343550 | 0.93 | PDE10A (0.41) | PDE10AKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL26343501 | 0.93 | MAPT (0.41) | PDE10AKDM4EMEN1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220384734-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220384734-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | MCOLN2, RER1, L1CAM | PDE10A 4471/4885KDM4E 3141/4885MEN1 228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.